These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22925530)

  • 1. Conformation of beta2glycoprotein I and its effect on coagulation.
    Ninivaggi M; Kelchtermans H; Lindhout T; de Laat B
    Thromb Res; 2012 Oct; 130 Suppl 1():S33-6. PubMed ID: 22925530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
    Yasuda S; Bohgaki M; Atsumi T; Koike T
    Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
    Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
    Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses against domain I of β(2)-glycoprotein I are driven by conformational changes: domain I of β(2)-glycoprotein I harbors a cryptic immunogenic epitope.
    de Laat B; van Berkel M; Urbanus RT; Siregar B; de Groot PG; Gebbink MF; Maas C
    Arthritis Rheum; 2011 Dec; 63(12):3960-8. PubMed ID: 21898342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
    Agar C; van Os GM; Mörgelin M; Sprenger RR; Marquart JA; Urbanus RT; Derksen RH; Meijers JC; de Groot PG
    Blood; 2010 Aug; 116(8):1336-43. PubMed ID: 20462962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of beta2-glycoprotein I on tissue factor activity.
    Ieko M; Yasukouchi T; Sawada KI; Koike T
    Semin Thromb Hemost; 1998; 24(3):211-5. PubMed ID: 9701450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
    de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.
    Shi T; Iverson GM; Qi JC; Cockerill KA; Linnik MD; Konecny P; Krilis SA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3939-44. PubMed ID: 15007174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions.
    Pozzi N; Acquasaliente L; Frasson R; Cristiani A; Moro S; Banzato A; Pengo V; Scaglione GL; Arcovito A; De Cristofaro R; De Filippis V
    J Thromb Haemost; 2013 Jun; 11(6):1093-102. PubMed ID: 23578283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.
    Bohgaki M; Atsumi T; Yamashita Y; Yasuda S; Sakai Y; Furusaki A; Bohgaki T; Amengual O; Amasaki Y; Koike T
    Int Immunol; 2004 Nov; 16(11):1633-41. PubMed ID: 15466912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG; Smith SA
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-molecular-weight heparin on adhesion and vesiculation of phospholipid membranes: a possible mechanism for the treatment of hypercoagulability in antiphospholipid syndrome.
    Frank M; Sodin-Semrl S; Rozman B; Potocnik M; Kralj-Iglic V
    Ann N Y Acad Sci; 2009 Sep; 1173():874-86. PubMed ID: 19758240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta 2 glycoprotein-I inhibits factor XII activation on triglyceride rich lipoproteins: the effect of antibodies from plasma of patients with antiphospholipid syndrome.
    McNally T; Mackie IJ; Isenberg DA; Machin SJ
    Thromb Haemost; 1996 Aug; 76(2):220-5. PubMed ID: 8865535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellagic acid/phospholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma.
    Shiozaki A; Niiya K; Higuchi F; Tashiro S; Arai T; Izumi R; Sakuragawa N
    Thromb Res; 1994 Oct; 76(2):199-210. PubMed ID: 7863469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoantibodies and thrombosis].
    Koike T
    Hokkaido Igaku Zasshi; 1997 Sep; 72(5):485-90. PubMed ID: 9363465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?
    Inanç M; Radway-Bright EL; Isenberg DA
    Br J Rheumatol; 1997 Dec; 36(12):1247-57. PubMed ID: 9448584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.